CARLSMED, INC. (CARL)
2025-06-30 | ||||
|---|---|---|---|---|
| Revenue | 12,083 | |||
| Cost of sales | 3,214 | |||
| Gross profit | 8,869 | |||
| Sales and marketing | 7,869 | |||
| Research and development | 4,160 | |||
| General and administrative | 3,342 | |||
| Total operating expenses | 15,371 | |||
| Loss from operations | -6,502 | |||
| Interest income | 336 | |||
| Interest expense | 363 | |||
| Change in fair value of warrant liabilities | 237 | |||
| Total other income (expense), net | -264 | |||
| Net loss | -6,766 | |||
| Deemed dividend to preferred stockholders | - | |||
| Net loss attributable to common stockholders | -6,766 | |||
| Earnings per share, basic | -1.47 | |||
| Earnings per share, diluted | -1.47 | |||
| Weighted average number of shares outstanding, basic | 4,589,717 | |||
| Weighted average number of shares outstanding, diluted | 4,589,717 | |||